Page 54 - TD-2-1
P. 54

Tumor Discovery                                                       LCP2 regulates melanoma progression



            2.6. Cell culture, stimulation, and cell transfection  Table 1. Primer sequences used for the RT‑qPCR

            A375 and B16F10 cells were purchased from ATCC. They   Gene             Primer sequence (5’ to 3’)
            were cultured in DMEM (01-052-1A, Biological Industries,   LCP2
            Israel) cell culture medium with 10% fetal bovine serum   Forward       AGAATGTCCCGTTTCGCTCAG
            (04-001-1ACS, Biological Industries, Israel). In cell culture
            experiments, transfection of LCP2 shRNA (GenePharma   Reverse           TGCTCCTTCTCTCTTCGTTCTT
            Biotechnology Company, Shanghai, China) was conducted   IRF5
            based on the operation manual. Non-targeting shRNA   Forward            AGAGACAGGGAAGTACACTGAAG
            was used as a control. shRNAs were transfected into A375   Reverse      TGGAAGTCACGGCTTTTGTTAAG
            and B16F10  cells with Lipofectaminected i (L3000015,   GAPDH
            Invitrogen) according to corresponding instructions. For   Forward      CTCTGCTCCTCCTGTTCGAC
            obtaining stable LCP2 knockdown cells, pMD2.G, psPAX2,
            and shRNA were cotransfected into HEK-293T cells with   Reverse         GCCCAATACGACCAAATCC
            TurboFect (R0532, Thermo Fisher Scientific) based on the   RT-qPCR: Real time-quantitative polymerase chain reaction
            corresponding operation manual. RT-PCR was used for   2.10. Identification of differentially expressed genes
            efficiency verification of transfection.
                                                               associated with LCP2
            2.7. Animal studies                                To further explore the mechanism of LCP2 regulating
            Female BALB/c nude mice (4-6 weeks old) and female C57BL/6   progression of melanoma, we analyzed the DEGs between
            mice (6-8 weeks old) were used for A375 experiments and   LCP2  knockdown  group  and control  group.  Ribo-Zero
            B16F10 experiments, respectively. 1ect A375 or B16F10 cells   rRNA removal kit was used to remove rRNA from 1 μg
                                         6
            (0.1 mL) were subcutaneously implanted to female nude or   of total RNA. TruSeq RNA sample prep kit (Illumina) was
            C57BL/6 mice. To determine tumor growth, a caliper was   used to generate sequencing libraries, and then sequenced
            used to record the tumor sizes every 5 days. All animal studies   as 151-bp paired-end reads using an Illumina HiSeq X
            were evaluated and approved by the Institutional Animal   Ten platform, with P < 0.05 and |foldchange| > 1 as cutoff
            Care and Use Committee of Xiangya Hospital, Central South   value.
            University (No. 2022020685).
                                                               2.11. Statistical analysis
            2.8. RT-qPCR
                                                               All data from the experiments are expressed as mean ± SEM.
            Tripure (Bio Teke, RP1002) and a reverse transcription kit   Statistical analyses of these data were performed using
            (HiScript Q RT, Vazyme, R223-01) were used to extract   GraphPad Prism 9 (GraphPad Software, La Jolla, CA) with
            the total RNA and reverse-transcribe RNA into cDNA,   an unpaired Student’s t-test or Tukey’s multiple comparison.
            respectively. The PCR system was prepared according to   P < 0.05 was set as a cutoff for significant difference.
            the SYBR qPCR Mix kit (Bimake, B21703). The relatively
            expression levels of LCP2 and IRF5 were detected by   3. Results
            normalization to GAPDH using ΔΔCt method. The primer   3.1. Identification of DEGs
            sequences used for the RT-qPCR are listed in Table 1.
                                                               Among the 2070 immune-centric genes, there were
            2.9. Flow cytometry                                1582  immune-centric  genes  in  GSE3189  data  set  and
            2% paraformaldehyde solution in phosphate-buffered   1842 in GSE31879 data set. Based on the criteria of FDR
            saline (PBS) was used for cell fixation, then stained with   q value < 0.01, the number of DEGs between melanoma
            fluorescent-labeled antibodies for cell-surface markers   and nevus, melanoma and normal skin, and melanoma and
            for 1 h at 4°C in the dark, and subsequently washed and   melanocyte were 720, 801, and 335, respectively, in GSE3189
            resuspended for flow cytometry analysis. The antibodies   and  GSE31879 data sets.  The  intersection  of  these  three
            used in this part are as follows: anti-mouse CD4 FITC   comparisons was 105, which were differently expressed
            (100406), anti-mouse CD45 APC (103112), anti-mouse   in all three comparisons (Figure 1A). Among 105 genes,
            CD4 PE (100407), anti-mouse/human Granzyme B       47 were confirmed as DEGs in GSE15605 (Figure 1B). GO
            PE (372208), AF647 anti-human/mouse Granzyme B     functional enrichment analysis showed that the changes
            antibody (515405), and anti-mouse CD8 APC (100766).   in 47 genes were mainly related to the biological processes
            The FACSCalibur (BD Biosciences) and FlowJo software   of neutrophil and autophagy (Figure 1C). KEGG pathway
            (Version 10.4) were used for flow cytometry analysis and   enrichment analysis demonstrated that these 47 DEGs
            data analysis, respectively.                       were significantly involved in lysosome, B-cell receptor


            Volume 2 Issue 1 (2023)                         4                           https://doi.org/10.36922/td.308
   49   50   51   52   53   54   55   56   57   58   59